Dihexa Peptide Therapy Memory & Cognition Beverly Hills FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths